📱 Now on iPhone — live scores, valuations & alerts on the go
Download iPhone App

Edgemode, Inc. (EDGM)

Healthcare Inconclusive inconclusive weak
$0.0
Updated: 2026-10-31

As of October 31, 2026, TradeApes rates Edgemode, Inc. (EDGM) 32 out of 100 (Weak); valuation verdict: Inconclusive.

32
TradeApes Score
Financial Strength
34 Weak
Operating Trend
100 Strong
Relative Value
0 Overvalued
Capital Allocation
27 Stressed
Risk Management
52 Mixed

EDGM is a type of company our standard valuation methods don't fit, so we don't publish a fair value for it.

Key Findings
What's working
  • + Return on invested capital 386% — earns well above its cost of capital
  • + Accruals are -692% of assets — earnings backed by cash
  • + Debt is 2% of assets — a light load
What to watch
  • − Earnings yield -196.2% (P/E about —) — no earnings to value
  • − Free-cash-flow yield -17.2% — no free cash to yield
  • − About 0.0 years of cash runway at the current burn — financing will be needed
AI-written analysis
The full Edgemode, Inc. (EDGM) analysis
Why the model reads EDGM as inconclusive, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.